Related Experiment Video
Updated: Jun 14, 2025
Assessment of Memory Function in Pilocarpine-induced Epileptic Mice
Published on: June 4, 2020
Senescent cell clearance ameliorates temporal lobe epilepsy and associated spatial memory deficits in mice
Abstract:
Current therapies for the epilepsies only treat the symptoms, but do not prevent epileptogenesis (the process in which epilepsy develops). Many cellular responses during epileptogenesis are also common hallmarks of cellular senescence , which halts proliferation of damaged cells. Clearing senescent cells (SCs) restores function in several age-associated and neurodegenerative disease models. It is unknown whether SC accumulation contributes to epileptogenesis and associated cognitive impairments. To address this question, we used a mouse model of temporal lobe epilepsy (TLE) and characterized the senescence phenotype throughout epileptogenesis. SCs accumulated 2 weeks after SE and were predominantly microglia. We ablated SCs and reduced (and in some cases prevented) the emergence of spontaneous seizures and normalized cognitive function in mice. Suggesting that this is a translationally-relevant target we also found SC accumulation in resected hippocampi from patients with TLE. These findings indicate that SC ablation after an epileptogenic insult is a potential anti-epileptogenic therapy.
Insights
Targeting cellular senescence, a process where damaged cells stop dividing, may prevent epilepsy development. Clearing these senescent cells (SCs) in mice reduced seizures and improved cognition, suggesting a new anti-epileptogenic therapy.
Area of Science:
- Neuroscience
- Cellular Biology
- Pathology
Background:
- Current epilepsy treatments manage symptoms but do not halt epileptogenesis, the process of epilepsy development.
- Cellular senescence, characterized by cell cycle arrest, shares hallmarks with cellular responses during epileptogenesis.
- Senescent cell (SC) accumulation is implicated in age-associated and neurodegenerative diseases, but its role in epilepsy is unexplored.
Purpose of the Study:
- To investigate the contribution of SC accumulation to epileptogenesis and associated cognitive deficits.
- To determine if SC ablation can serve as an anti-epileptogenic therapy.
Main Methods:
- Utilized a mouse model of temporal lobe epilepsy (TLE) induced by SE.
- Characterized SC accumulation and phenotype throughout epileptogenesis.
- Employed SC ablation strategies in mice.
- Analyzed SCs in hippocampal tissues from TLE patients.
Main Results:
- SCs, predominantly microglia, accumulated in the hippocampus two weeks after SE.
- Ablation of SCs significantly reduced the incidence and severity of spontaneous seizures.
- Cognitive functions were normalized in mice following SC ablation.
- SC accumulation was confirmed in TLE patient hippocampi, indicating translational relevance.
Conclusions:
- SC accumulation is a key factor in epileptogenesis and associated cognitive impairments.
- Targeting and clearing senescent cells post-insult represents a promising anti-epileptogenic therapeutic strategy.
- SC ablation offers a potential disease-modifying approach for TLE.
